Armata Pharmaceuticals
Stock Forecast, Prediction & Price Target
Armata Pharmaceuticals Financial Estimates
Armata Pharmaceuticals Revenue Estimates
Armata Pharmaceuticals EBITDA Estimates
Armata Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $4.47M N/A | $5.50M 23.11% | $4.52M -17.77% | Avg: $2.75M Low: $2.70M High: $2.79M avg. -39.28% | Avg: $9.13M Low: $8.97M High: $9.29M avg. 232.07% | Avg: $6.09M Low: $5.98M High: $6.19M avg. -33.31% | Avg: $56.29M Low: $55.30M High: $57.27M avg. 824.35% |
Net Income
% change YoY
| $-23.21M N/A | $-36.88M -58.86% | $-69.04M -87.17% | Avg: $-67.64M Low: $-56.63M High: $-37.15M avg. 2.02% | Avg: $-97.09M Low: $-31.36M High: $-29.96M avg. -43.54% | Avg: $-15.15M Low: $-15.49M High: $-14.80M avg. 84.39% | Avg: $-3.24M Low: $-3.32M High: $-3.17M avg. 78.57% |
EBITDA
% change YoY
| $-22.64M N/A | $-36.05M -59.19% | $-39.91M -10.71% | Avg: $-1.65M Low: $-1.67M High: $-1.62M avg. 95.86% | Avg: $-5.47M Low: $-5.57M High: $-5.38M avg. -232.07% | Avg: $-3.65M Low: $-3.71M High: $-3.58M avg. 33.31% | Avg: $-33.77M Low: $-34.36M High: $-33.18M avg. -824.35% |
EPS
% change YoY
| -$0.96 N/A | -$1.08 -12.50% | -$1.91 -76.85% | Avg: -$1.3 Low: -$1.57 High: -$1.03 avg. 31.93% | Avg: -$0.85 Low: -$0.87 High: -$0.83 avg. 34.61% | Avg: -$0.42 Low: -$0.43 High: -$0.41 avg. 50.58% | Avg: -$0.09 Low: -$0.09 High: -$0.09 avg. 78.57% |
Operating Expenses
% change YoY
| $23.82M N/A | $36.94M 55.09% | $11.64M -68.47% | Avg: $8.93M Low: $8.77M High: $9.08M avg. -23.33% | Avg: $29.65M Low: $29.13M High: $30.17M avg. 232.07% | Avg: $19.77M Low: $19.43M High: $20.12M avg. -33.31% | Avg: $182.81M Low: $179.61M High: $186.01M avg. 824.35% |
FAQ
What is Armata Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 30.36% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -56.63M, average is -67.64M and high is -37.15M.
What is Armata Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 245.95% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $2.70M, average is $2.75M and high is $2.79M.
What is Armata Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 48.92% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.57, average is -$1.3 and high is $-1.03.